Microfabrication and Characterization of Chemically Actuated Implantable PLGA Reservoir-based Device for Controlled Drug Delivery

References

• J. Wanigasekara, and C. Witharana, “Applications of nanotechnology in drug delivery and design – an insight,” Curr. Trends. Biotechnol. Pharm., Vol. 10, no. 1, pp. 78–91, 2016.
   Google Scholar
• V. P. Torchilin, et al., “Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery,” Nat. Rev. Drug Discovery, Vol. 13, no. 11, pp. 813–27, 2014.
   PubMed Web of Science ®Google Scholar
• E. K. Efthimiadou, et al., “Stimuli-responsive biopolymer nanocarriers for drug delivery applications,” Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications., Vol. 1, pp. 405–32, 2018.
   Google Scholar
• B. Wang, et al., “Wang, Bo, et al. “Recent advances in polymer-based drug delivery systems for local anesthetics.” Acta biomaterialia., 96: 55–67, 2019.
   PubMed Web of Science ®Google Scholar
• T. Chen, et al., “Intelligent drug delivery system based on mesoporous silica nanoparticles coated with an ultra-pH-sensitive gatekeeper and poly (ethylene glycol),” ACS Macro Lett., Vol. 5, no. 1, pp. 55–8, 2016.
   PubMed Web of Science ®Google Scholar
• L. Dong, et al., “The smart drug delivery system and its clinical potential,” Theranostics, Vol. 6, no. 9, pp. 1306, 2016.
   PubMed Web of Science ®Google Scholar
• X. Chen, et al., “Charge-reversal nanoparticles: novel targeted drug delivery carriers,” Acta Pharm Sin B, Vol. 6, no. 4, pp. 261–7, 2016.
   PubMed Web of Science ®Google Scholar
• S. Sharma, et al., “Vitamin B6 tethered endosomal pH responsive lipid nanoparticles for triggered intracellular release of doxorubicin,” ACS Appl. Mater. Interfaces, Vol. 8, no. 44, pp. 30407–21, 2016.
   PubMed Web of Science ®Google Scholar
• F. I. Uchegbu, and  Andreas G. Schatzlein, eds. Polymers in drug delivery. CRC Press, 2006.
   Google Scholar
• B. Wang, L. Hu, and T. J. Siahaan, Drug delivery: principles and applications. John Wiley & Sons, 2016.
   Google Scholar
• L. J. Lee, “Polymer nanoengineering for biomedical applications,” Ann. Biomed. Eng., Vol. 34, no. 1, pp. 75–88, 2006.
   PubMedGoogle Scholar
• P. Q. Ruhe, et al., “rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites,” J. Bone Joint Surg. Am., Vol. 85, no. suppl 3, pp. 75–81, 2003.
   PubMedGoogle Scholar
• C. Rabin, et al., “In vitro and in vivo demonstration of risperidone implants in mice,” Schizophr. Res., Vol. 98, no. 1, pp. 66–78, 2008.
   PubMedGoogle Scholar
• A. Ahmed, et al., “Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery,” J. Controlled Release, Vol. 81, no. 3, pp. 291–306, 2002.
   PubMed Web of Science ®Google Scholar
• S. L. Tao, and A. T. Desai, “Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability,” J. Controlled Release, Vol. 109, no. 1, pp. 127–38, 2005.
   PubMedGoogle Scholar
• D. Klose, et al., “PLGA-based drug delivery systems: importance of the type of drug and device geometry,” Int. J. Pharm., Vol. 354, pp. 95–103, 2008.
   PubMed Web of Science ®Google Scholar
• H. K. Makadia, and S. J. Steven, “Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier,” Polymers), Vol. 3, no. 3, pp. 1377–97, 2011.
   PubMed Web of Science ®Google Scholar
• S. Alimohammadi, et al., “PLGA-based nanoparticles as cancer drug delivery systems,” Asian Pac. J. Cancer Prev., Vol. 15, pp. 517–35, 2014.
   PubMedGoogle Scholar
• R. Xiaojiao, et al., “Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice,” Drug Delivery, Vol. 19, no. 1, pp. 36–44, 2012.
   PubMedGoogle Scholar
• L. C. Stevenson, et al., “Reservoir-based drug delivery systems utilizing microtechnology,” Adv. Drug Delivery Rev., Vol. 64, no. 14, pp. 1590–602, 2012.
   PubMed Web of Science ®Google Scholar
• A. L. Thangawng, et al., “An ultra-thin PDMS membrane as a bio/micro–nano interface: fabrication and characterization,” Biomed. Microdevices, Vol. 9, no. 4, pp. 587–95, 2007.
   PubMed Web of Science ®Google Scholar
• A. Rösler, et al., “Advanced drug delivery devices via self-assembly of amphiphilic block copolymers,” Adv. Drug Delivery Rev., Vol. 64, pp. 270–9, 2012.
   Web of Science ®Google Scholar
• J. D’sa, D. Sachan, and M. Goswami, “Fabrication of stress and temperature measurement sensors and possible integration with fabricated biodegradable drug delivery device,” IETE. J. Res., Vol. 67, no. 6, pp. 826–34, 2021.
   Google Scholar
• J. Dsa, M. Goswami, B. R. Singh, N. Bhatt, P. Sharma, and M. K. Chauhan, “Design and fabrication of a magnetically actuated non-invasive reusable drug delivery device,” Drug Dev. Ind. Pharm., Vol. 44, no. 7, pp. 1070–7, 2018.
   PubMed Web of Science ®Google Scholar
• R. Dorati, et al., “Investigation of the degradation behaviour of poly (ethylene glycol-co-D, L-lactide) copolymer,” Polym. Degrad. Stab., Vol. 92, no. 9, pp. 1660–68, 2007.
   Google Scholar
• T. G. Park, “Degradation of poly (lactic-co-glycolic acid) microspheres: effect of copolymer composition,” Biomaterials, Vol. 16, no. 15, pp. 1123–30, 1995.
   PubMed Web of Science ®Google Scholar
• C. H. Sonam, et al., “Effect of physicochemical properties of biodegradable polymers on nano drug delivery,” Polym. Rev., Vol. 53, no. 4, pp. 546–67, 2013.
   Web of Science ®Google Scholar
• J. Choi, et al., “Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly (lactic-co-glycolic acid),” Langmuir, Vol. 30, no. 33, pp. 10098–106, 2014.
   PubMedGoogle Scholar
• M. Ramchandani, and D. Robinson, “In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants,” J. Controlled Release, Vol. 54, no. 2, pp. 167–75, 1998.
   PubMedGoogle Scholar
• R. Yang, et al., “Microfabrication of biodegradable (PLGA) honeycomb-structures and potential applications in implantable drug delivery,” Sens. Actuators B, Vol. 106, no. 2, pp. 506–511, 2005.
   Google Scholar